A short study cannot settle years of risk
CJC-1295 safety studies leave long-term risks unknown
Puffy hands may catch your eye before a changed blood sugar reading. The small studies leave both visible effects and harder-to-see risks needing a closer look.
The short safety answer is that lasting risks remain unknown
Swollen fingers are plain to see, while blood sugar changes can be hidden. You need more than what you can see to judge lasting safety.
CJC-1295 has no approved use backed by lasting safety findings
No major drug authority has approved CJC-1295 for use in people. Swelling, the rise of a protein made after growth hormone, and immune-system reactions raise concerns.
FDA advisers raised the immune-system concern during a pharmacy review in 2024. A confident safety claim doesn't answer a risk that studies haven't settled.
CJC-1295 peptides were tested briefly, not over years
The published CJC-1295 work checked blood changes in short human studies [1][3]. Growth hormone and the protein made afterward rose, raising fluid and cancer questions.
The 2024 FDA pharmacy review also raised concern about the immune system's response. The concern isn't proof of harm, but brief studies can't rule out lasting harm.
CJC-1295 may leave more fluid and sugar in the body
Growth hormone can make kidneys hold extra salt, with water building up. Insulin normally helps sugar leave blood and enter cells; growth hormone can weaken that help.
The liver makes a protein after growth hormone rises; higher amounts are linked with some cancer risks. FDA's other concern was the immune system reacting against the compound.
Several concerns remain without a reliable measure of your risk
More growth hormone can mean fluid buildup or less help from insulin. More of the protein made afterward has been linked with certain cancer risks.
FDA's 2024 pharmacy review raised immune-system concerns about compounds including CJC-1295. No lengthy comparison study in healthy adults has established the size of those risks [1].
The gland’s hormone response differs from muscle-building steroids
CJC-1295 lasts longer when the changed chain also has an attachment
Four changes help protect the made copy from early breakdown [7]. With DAC, a protein in blood keeps the copy attached for days [2].
The unattached Modified GRF 1-29 form breaks down in a matter of minutes or hours [8]. You need the form named when judging claims about the length of action.
CJC-1295 raised two blood readings without proving health gains
The study involved healthy men, limiting what the findings can tell you. At the follow-up a week later, growth hormone's average was about 46% higher; the other protein rose about 45% [3].
CJC-1295 does not act like muscle-building steroids
A peptide consists of amino acids, the small parts joined together in proteins. Your gland responds to this peptide by releasing more of its own growth hormone.
Muscle-building steroids work like male sex hormones, which is a different action. A different action still leaves the question of lasting safety unanswered.
The compound lacks approval for human use and is banned in sports
CJC-1295 FDA approved claims have no basis
FDA hasn't approved CJC-1295 for people, nor has another major drug authority. In 2024, FDA advisers opposed adding the compound to a list permitting ingredients in certain pharmacy-made medicines.
Listing would let certain pharmacies use the ingredient when making medicines for individual patients. Concern about an immune-system reaction helped explain why the advisers opposed listing.
CJC-1295 is banned at all times under Section S2 of World Anti-Doping Agency rules. NCAA rules also prohibit the compound in college sports, with lab testing able to detect use.
Researchers found CJC-1295 in a seized drug preparation described as a growth-hormone-releasing hormone [6]. The lab finding named the ingredient; the broad description hadn't named that specific compound.
Reviews explain how lab tests detect these made copies in sports testing [14][15]. Detecting a compound tells you what was found, not whether use is safe.
CJC-1295 studies did not measure the male sex hormone testosterone
Testosterone is a male sex hormone that helps maintain muscle and sexual function. CJC-1295 studies measured growth hormone and the protein made afterward, rather than testosterone [1][3].
The tested hormones cannot answer your testosterone question
CJC-1295's action raises growth hormone, rather than acting like a male sex hormone. The human studies don't establish whether the male sex hormone rises or falls.
CJC-1295 has no study finding establishing a testosterone fall
The published studies didn't track the male sex hormone while testing growth hormone. That missing measurement prevents a claim that CJC-1295 lowers testosterone.
CJC-1295 has no study finding establishing a testosterone rise
The same missing measurement prevents a claim that CJC-1295 raises the male sex hormone. For you, higher growth hormone gives no answer about the male sex hormone's level.
Approved testosterone treatment has been studied more fully
Approved testosterone treatment replaces a low hormone level and is watched by a doctor [1]. CJC-1295 remains unapproved, with only short, early human studies to judge.
Studies of the related approved compound tesamorelin tested people with HIV who had excess belly fat [13]. That separate approval doesn't establish safer treatment than testosterone for you.